首页> 外文期刊>Journal of substance abuse treatment >Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis
【24h】

Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis

机译:联邦物质的解释和整合在综合卫生系统中使用隐私保护规则:定性分析

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundFederal regulations (42 CFR Part 2) provide special privacy protections for persons seeking treatment for substance use disorders. Primary care providers, hospitals, and health care organizations have struggled to balance best practices for medical care with adherence to 42 CFR Part 2, but little formal research has examined this issue. The aim of this study was to explore institutional variability in the interpretation and implementation of 42 CFR Part 2 regulations related to health systems data privacy practices, policies, and information technology architecture. MethodsThis was a cross-sectional qualitative study using purposive sampling to conduct interviews with privacy/legal officers (n?=?17) and information technology specialists (n?=?10) from 15 integrated healthcare organizations affiliated with three research nodes of the National Institute on Drug Abuse (NIDA) National Drug Abuse Treatment Clinical Trials Network (CTN). Trained staff completed a short survey and digitally recorded semi-structured qualitative interview with each participant. Interviews were transcribed and coded within Atlas.ti. Framework analysis was used to identify and organize key themes across selected codes. ResultsParticipants voiced concern over balancing patient safety with 42 CFR Part 2 privacy protections. Although similar standards of protection regarding release of information outside of the health system was described, numerous workarounds were used to manage intra-institutional communication and care coordination. To align 42 CFR Part 2 restrictions with electronic health records, health systems used sensitive note designation, “break the glass” technology, limited role-based access for providers, and ad hoc solutions (e.g., provider messaging). ConclusionsIn contemporary integrated care systems, substance-related EHR records (e.g., patient visit history, medication logs) are often accessible internally without specific consent for sharing despite the intent of 42 CFR Part 2. Recent amendments to 42 CFR Part 2 have not addressed information sharing needs within integrated care settings.
机译:BackgroundFederal法规(42 CFR第2部分)为寻求物质使用障碍治疗的人提供特殊的隐私保护。初级保健提供者,医院和医疗保健组织努力平衡医疗保健的最佳实践,并遵守42 CFR第2部分,但很少的正规研究已经审查了这个问题。本研究的目的是探讨与卫生系统数据隐私惯例,政策和信息技术架构有关的42 CFR第2条规定的解释和实施中的制度变异性。方法是使用有目的采样进行横断面定性研究,以便与隐私/法律官员进行访谈(n?=?17)和信息技术专家(n?=?10)来自与国家三个研究节点附属的15个综合医疗保健组织药物滥用研究所(NIDA)国家药物滥用治疗临床试验网络(CTN)。训练有素的工作人员完成了一项简短的调查,并与每个参与者进行了数量录制了半结构性的定性访谈。采访被转录并在阿特拉斯境内编码。框架分析用于识别和组织各种代码的关键主题。结果专家股票对平衡患者安全有关的关注,42 CFR第2部分隐私保护。尽管描述了关于卫生系统之外的信息释放的类似标准,但众多解决方法用于管理体制内部沟通和关心协调。将42 CFR第2部分与电子健康记录进行限制,卫生系统使用敏感性票据指定,“打破玻璃”技术,有限的基于角色的访问权限,以及临时解决方案(例如,提供商消息传递)。结论当代综合保健系统,物质相关的EHR记录(例如,患者访问历史,药物原木)通常可以在内部访问,而无需具体同意,尽管42 CFR第2部分意图的意图。近期修订了42 CFR第2部分没有解决的信息在集成的小心设置内共享需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号